Filing Details
- Accession Number:
- 0001209191-17-042617
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-06-30 19:32:43
- Reporting Period:
- 2017-06-28
- Filing Date:
- 2017-06-30
- Accepted Time:
- 2017-06-30 19:32:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1422997 | Petrus Bekker | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-06-28 | 30,000 | $7.10 | 89,839 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-28 | 30,000 | $9.12 | 59,839 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-06-29 | 5,509 | $7.10 | 65,348 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-29 | 5,509 | $9.11 | 59,839 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 11,991 | $7.10 | 71,830 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-30 | 11,991 | $9.12 | 59,839 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-06-30 | 18,009 | $6.30 | 77,848 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-06-30 | 18,009 | $9.30 | 59,839 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2017-06-28 | 30,000 | $0.00 | 30,000 | $7.10 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-06-29 | 5,509 | $0.00 | 5,509 | $7.10 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-06-30 | 11,991 | $0.00 | 11,991 | $7.10 |
| Common Stock | Stock Option (right to buy) | Disposition | 2017-06-30 | 18,009 | $0.00 | 18,009 | $6.30 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 160,000 | 2024-02-19 | No | 4 | M | Direct | |
| 154,491 | 2024-02-19 | No | 4 | M | Direct | |
| 142,500 | 2024-02-19 | No | 4 | M | Direct | |
| 29,751 | 2020-08-10 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $9.10 to $9.16 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $9.10 to $9.20 per share, inclusive. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- As of June 28, 2017, and prior to this transaction, the exercised options were fully vested.
- Not applicable.
Billionaire Hedge Funds
